First Iraqi Bank Announces Iraq’s Fully Digital Bank, Gears for a Cashless Economy in the Country
Arasat Al Hindi, Iraq–(Newsfile Corp. – December 12, 2022) – First Iraqi Bank has officially…
Month: December 2022
PET CASTLE PROTOCOL (PCP) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – December 12, 2022) – LBank Exchange, a global digital asset…
BHP, I-Pulse and I-ROX Enter into Strategic Collaboration to Advance New Applications of I-Pulse Technology
Pulsed power could transform mining and decarbonise key steps of the mineral extraction process BHP…
Lithosphere (LITHO) Blockchain Announces Plans to Support & Burn 100T Shiba Inu in Finesse P2E Series’ SHIB Metaverse
Seattle, Washington–(Newsfile Corp. – December 12, 2022) – Lithosphere developer KaJ Labs has announced that…
ROOKIE Racing and TOYOTA announce participation in 25-hour endurance race in Thailand
TOKYO, Dec 12, 2022 – (JCN Newswire) – ROOKIE Racing Co., Ltd. (ROOKIE Racing) and…
Society Pass (Nasdaq: SOPA) to Present at the #Adapt International Convention 2022 on 13-14 December 2022
SINGAPORE, Dec 12, 2022 – (ACN Newswire) – Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast…
insightsoftware Takes Jet Analytics to the Cloud
Adopting a new SaaS model, Jet Analytics Cloud is delivered via Microsoft Azure to provide…
Renesas Wins 2022 “Outstanding Asia-Pacific Semiconductor Company Award” by Global Semiconductor Alliance
TOKYO–(BUSINESS WIRE)–#2022GSAawards–Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced…
Generac Holdings Inc. (GNRC) Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Generac Holdings Inc.
SAN DIEGO–(BUSINESS WIRE)–$GNRC #GNRC—The Class: Robbins LLP reminds investors that a shareholder filed a class…
Fujitsu Joins Scholarship Partner Program of Kamiyama Marugoto College of Design, Engineering and Entrepreneurship, Contributes One Billion Yen to Scholarship Fund
TOKYO, Dec 12, 2022 – (JCN Newswire) – Fujitsu today announced that it joined a…
Agios Presents Updated PYRUKYND® (mitapivat) Long-term Extension Data Demonstrating Sustained Clinical Benefits in Adults with Pyruvate Kinase (PK) Deficiency at 64th ASH Annual Meeting and Exposition
– Data Suggest Long-term Treatment with PYRUKYND® in Adults with PK Deficiency is Associated with…
InvesTech Holdings and NTT Jointly Launch Smart Office SaaS Service Platform
HONG KONG, Dec 12, 2022 – (ACN Newswire) – InvesTech Holdings Limited (“InvesTech Holdings”; together…
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
– 89% ORR in TKI-therapy naïve patients; 73% ORR in all evaluable patients with 27-week…
Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual Meeting
Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully immunocompetent…
Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting
Media Release COPENHAGEN, Denmark; December 11, 2022 Epcoritamab featured in multiple data disclosures, including four…
Press Release: Statement from Sanofi regarding Horizon Therapeutics plc (“Horizon”)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR…
Ryvu Therapeutics Presents Clinical and Translational Data of RVU120 and SEL24 (MEN1703) at the 2022 American Society of Hematology (ASH) Annual Meeting
RVU120 Demonstrates Single-Agent Activity with a Complete Response, 4 Blast Reductions, and 4 Erythroid and/or Platelet…
Vincerx Pharma Presents Preclinical Data on VIP943 in Acute Myeloid Leukemia Models at the 64th American Society of Hematology Annual Meeting 2022
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC),…
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations MOUNTAIN VIEW, Calif., Dec….
Kronos Bio Presents Preclinical Data Supporting Anti-Leukemic Activity of Lanraplenib in Combination with Multiple Targeted Agents in Acute Myeloid Leukemia (AML) Preclinical Models at American Society of Hematology Meeting
Lanraplenib is being evaluated in ongoing Phase 1b/2 trial in combination with gilteritinib in patients…